共 50 条
Prognostic and Therapeutic Implications of Frailty in Older Adults with Heart Failure
被引:20
|作者:
Goldfarb, Michael
[1
]
Sheppard, Richard
[1
]
Afilalo, Jonathan
[1
,2
]
机构:
[1] McGill Univ, Div Cardiol, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Ctr Clin Epidemiol, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada
关键词:
Heart failure;
Frailty;
Therapy;
Outcomes;
VENTRICULAR ASSIST DEVICE;
COMPREHENSIVE GERIATRIC ASSESSMENT;
ADVERSE DRUG-REACTIONS;
ELDERLY-PATIENTS;
DESTINATION THERAPY;
RANDOMIZED-TRIALS;
BODY-COMPOSITION;
CLINICAL-TRIALS;
MUSCLE STRENGTH;
TERM MORTALITY;
D O I:
10.1007/s11886-015-0651-3
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Frailty is increasingly recognized in older adults with cardiovascular disease, particularly in those with heart failure (HF). A growing body of evidence has shown that frailty has a negative effect on survival, hospitalizations, disability, and quality of life. Beyond frailty, additional domains captured by a comprehensive geriatric assessment contribute incremental value in predicting outcomes and identifying treatment targets. Exercise training is ideally suited to this setting as it can concomitantly improve physical frailty and HF symptoms. Multidisciplinary disease management programs offer a number of benefits for frail HF patients; invasive procedures carry a higher risk of morbidity than in non-frail counterparts, and evidence-based drugs and devices have an uncertain value and warrant further research. While more data accrues, difficult therapeutic decisions should be individualized using a shared patient-centered decision making approach.
引用
收藏
页数:7
相关论文